Abstract |
Survivin is a protein which functions as a mitotic regulator as well as apoptosis inhibitor. In this study, we show that introduction of synthetic miR-542-3p mimetic reduced both mRNA and protein levels of survivin. In A549 cells, luciferase reporter assay revealed that miR-542-3p targeted predicted binding sites in the 3'-untranslated region (3'-UTR) of survivin. We also demonstrate that ectopic expression of miR-542-3p inhibited cell proliferation by inducing Gap 1 (G1) and Gap 2/Mitosis (G2/M) cell cycle arrest. Collectively, these results suggest that survivin is a direct target of miR-542-3p and growth inhibition by miR-542-3p may have a potential utility as an anti- cancer therapy.
|
Authors | Sena Yoon, Young-Chul Choi, Suman Lee, Yongsu Jeong, Jaeseung Yoon, Kwanghee Baek |
Journal | FEBS letters
(FEBS Lett)
Vol. 584
Issue 18
Pg. 4048-52
(Sep 24 2010)
ISSN: 1873-3468 [Electronic] England |
PMID | 20728447
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- BIRC5 protein, human
- Inhibitor of Apoptosis Proteins
- MicroRNAs
- Microtubule-Associated Proteins
- Survivin
|
Topics |
- Cell Cycle
(genetics)
- Cell Line, Tumor
- Cell Proliferation
- Gene Expression Regulation, Neoplastic
- Humans
- Inhibitor of Apoptosis Proteins
- MicroRNAs
(genetics, metabolism)
- Microtubule-Associated Proteins
(genetics)
- Mitosis
(genetics)
- Oligonucleotide Array Sequence Analysis
- Survivin
|